For citations:
Egshatyan L.V. A novel calcimimetic evocalcet for the management of secondary hyperparathyroidism with little effect on the gastrointestinal tract and cyp isozymes in vivo and in vitro. Osteoporosis and Bone Diseases. 2019;22(3):27-33. (In Russ.) https://doi.org/10.14341/osteo12309
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (CC BY-NC-ND 4.0).
Email this article 
